Only by understanding the Ebola virus and other pathogens, which cause so much suffering in countries like Sierra Leone, can we take meaningful steps to protect communities from future outbreaks
- Ian Goodfellow
The team of British scientists, funded by the Wellcome Trust, is using semi-conductor next-generation sequencing technology developed by Thermo Fisher Scientific to generate data in a lab facilitated by Public Health England and International Medical Corps. The genetic analysis is being made freely available to the scientific community.
Since the first reported case in March 2014, the Ebola outbreak has claimed nearly 11,000 lives in West African countries. Professor Ian Goodfellow, Head of Virology at the University of Cambridge, travelled to Sierra Leone in December last year and then again in March this year to help set up a new diagnostics centre attached to an Ebola Treatment Centre in one of the country’s worst affected parts. He returned a third time, together with his postdoc Dr Armando Arias, to study the virus at a molecular level using the sequencing technology.
“Sequencing the genome of a virus can tell us a lot about how it spreads and changes as it passes from person to person. While this information is invaluable to researchers, the rapid sharing of data does not always occur,” said Professor Paul Kellam at the Wellcome Trust Sanger Institute, who is leading the team to map the genomic data captured by Professof Goodfellow and colleagues. “It used to take months to process samples that had to be brought back to labs in the UK for analysis. Having sequencing capabilities on the ground helps generate data in a matter of days or at the longest weeks, which should have a profound impact on how the Ebola virus is researched and inevitably addressed on a global scale.”
Read the full story
Image: Ebola virus
Credit: CDC Global
Reproduced courtesy of the University of Cambridge
______________________________________________